Ingevity Corp Stock Price, News & Analysis

Ingevity (NYSE:NGVT) has scheduled its second-quarter 2025 earnings release for Monday, August 4, 2025, after market close. The company will host a webcast and conference call on Tuesday, August 5, at 10:00 a.m. (Eastern) to discuss the results.

Investors can access the webcast through Ingevity's website or join via phone using the access code 590026. A recording will be available from August 5, 2025, through August 4, 2026. The company will provide a slide deck with financial and statistical information prior to the call.

Ingevity operates in three segments: Performance Materials, Advanced Polymer Technologies, and Performance Chemicals, serving various industries with sustainable solutions through its 24 global locations and 1,600 employees.

Ingevity Corporation (NYSE:NGVT) has released its 2024 Sustainability Report, titled "Powering a Cleaner, More Sustainable Tomorrow." The report showcases the company's commitment to sustainable solutions, highlighting that 73% of their raw materials are renewable. Key achievements include reaching the ACC's top-quartile safety performance rating ahead of schedule, expanding ISCC+ certification across all Capa® product lines, and being recognized among Newsweek's "America's Most Responsible Companies of 2025" for the third consecutive year.

The company operates through three segments: Performance Materials, Advanced Polymer Technologies, and Performance Chemicals, serving various industries from automotive components to biodegradable bioplastics. With approximately 1,600 employees across 24 global locations, Ingevity continues to focus on developing technologies that purify, protect, and enhance the world.

Ingevity Corporation (NYSE:NGVT) announced the departure of Ed Woodcock, executive vice president and president of Performance Materials, effective July 1, 2025. Woodcock concludes a 37-year career with the company, during which he led the growth of Ingevity's Performance Materials activated carbon business in automotive emissions capture.

The company has initiated a search for a new segment leader. In the interim, the Performance Materials segment will be managed by Andrew Fox, vice president, Performance Materials and president of the Asia-Pacific region, and Jonathan MacIver, vice president global commercial, Performance Materials. Woodcock will remain available to assist with the leadership transition.

Ingevity confirmed that there are no changes to its previously disclosed full-year guidance.

Ingevity (NYSE: NGVT) reported Q1 2025 financial results with net sales of $284.0 million, down 17% year-over-year. The company posted net income of $20.5 million and diluted EPS of $0.56, including before-tax special charges of $20.2 million. Adjusted EBITDA increased 23% to $91.3 million with margins improving to 32.1%. Performance Materials segment saw 1% sales growth to $146.8 million, while Advanced Polymer Technologies sales declined 12% to $42.2 million. Performance Chemicals sales dropped 35% to $95.0 million due to strategic repositioning. The company revised its full-year 2025 guidance to sales between $1.25-1.40 billion and adjusted EBITDA of $380-415 million, citing lower auto production forecasts due to trade tensions.

Ingevity (NYSE: NGVT) has scheduled its first-quarter 2025 earnings release for Monday, May 5, 2025, after market close. The company will host a webcast discussion on Tuesday, May 6, at 9:00 a.m. (Eastern).

Participants can access the webcast through Ingevity's investor section or dial in using 833-470-1428 (U.S.) with access code 815699. A recording will be available from 2:00 p.m. (Eastern) on May 6, 2025, through May 5, 2026.

Ingevity operates in three segments: Performance Materials (activated carbon), Advanced Polymer Technologies (caprolactone polymers), and Performance Chemicals (specialty chemicals and road technologies). The company employs approximately 1,600 people across 24 global locations.

Ingevity (NYSE: NGVT) has filed its definitive proxy statement for the 2025 Annual Meeting and issued a letter to stockholders highlighting recent transformational changes and financial performance. The company has implemented significant business changes including facility closures, raw material supply restructuring, and portfolio optimization.

Key financial achievements in 2024 include:

• Revenue of $1.4+ billion
• Adjusted EBITDA of $362+ million (26% margin)
• Cost savings of $84 million
• Free cash flow of $51 million

The company projects 10-14% adjusted EBITDA growth for 2025, with free cash flow expected to increase 4-5x from 2024 levels. David H. Li has been appointed as the new President and CEO, effective April 7, 2025. The company is currently in a proxy fight with Vision One, which has nominated two directors for election. Ingevity urges stockholders to vote 'FOR' their nine director nominees on the WHITE proxy card.

Ingevity (NYSE:NGVT) has appointed David H. Li as president and CEO, effective April 7, 2025. Li, who brings over 25 years of experience in the specialty materials industry, will succeed interim president and CEO Luis Fernandez-Moreno, who will remain on the board.

Li previously served as CEO, president and board member of CMC Materials, Inc., a global supplier of advanced materials for semiconductor and energy industries, until its sale to Entegris, Inc. in 2022. Board chair Jean Blackwell highlighted Li's proven track record in repositioning businesses and achieving substantial growth, strong financial performance, and outstanding stockholder returns.

Under Fernandez-Moreno's interim leadership since October 2024, Ingevity has implemented strategic initiatives, including portfolio management, resulting in improved operational performance and free cash flow generation.

Ingevity (NYSE: NGVT) has highlighted significant progress in its strategic initiatives to enhance business performance. The company achieved record performance in its Performance Materials division, with margins exceeding 50% in 2024, driven by new pricing and operational efficiency initiatives.

The company's Performance Chemicals segment transformation delivered $84 million in savings in 2024, surpassing their $65-75 million target. They expect additional savings of $10-25 million in 2025. Second-half EBITDA margins increased to approximately 28%, with improved free cash flow.

Ingevity announced a strategic alternatives review for their Industrial Specialties product line and North Charleston CTO refinery, expecting to communicate decisions by year-end. The company targets $400-415 million in EBITDA for 2025 and aims to reduce net leverage ratio below 2.8x by year-end 2025.

Ingevity (NYSE: NGVT) reported Q4 2024 net sales of $298.8 million, down 20% year-over-year, with net income of $16.6 million and diluted EPS of $0.46. Q4 adjusted EBITDA was $80.6 million with a 27.0% margin.

For full-year 2024, the company reported net sales of $1.4 billion, down 17% from 2023. The company recorded a net loss of $430.3 million, including a $349.1 million goodwill impairment and $338.9 million in special charges. Full-year adjusted EBITDA was $362.7 million with a 25.8% margin.

Looking ahead, Ingevity provided 2025 guidance with sales between $1.3-1.4 billion, adjusted EBITDA of $400-415 million, and free cash flow of $220-260 million. The company announced plans to explore strategic alternatives for its Performance Chemicals Industrial Specialties product line and North Charleston CTO refinery.